Ftse Mib
34.395,62
0,06%
DAX
18.518,03
-0,44%
S&P 500
5.647,55
0,29%
NASDAQ
18.434,37
-0,21%
Bitcoin
64.413,71
-0,68%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Applied Therapeutics Inc (APLT) Applied Therapeutics Inc (APLT) Notizie

APLT

Applied Therapeutics (APLT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APLT
DataOraFonteTitoloSimboloCompagnia
26/02/202022:05GlobeNewswire Inc.Applied Therapeutics to Present at the Cowen and Company 40th Annual Health Care ConferenceNASDAQ:APLTApplied Therapeutics Inc
15/02/202007:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APLTApplied Therapeutics Inc
14/02/202023:40Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:APLTApplied Therapeutics Inc
14/02/202023:30Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APLTApplied Therapeutics Inc
14/02/202014:16Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:APLTApplied Therapeutics Inc
28/01/202018:24GlobeNewswire Inc.Applied Therapeutics, Inc. Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchas...NASDAQ:APLTApplied Therapeutics Inc
24/01/202003:28GlobeNewswire Inc.Applied Therapeutics, Inc. Announces Upsizing and Pricing of Public Offering of 2,741,489 Shares of Common StockNASDAQ:APLTApplied Therapeutics Inc
21/01/202022:16GlobeNewswire Inc.Applied Therapeutics, Inc. Announces Offering of 1,750,000 Shares of Common StockNASDAQ:APLTApplied Therapeutics Inc
08/01/202013:00GlobeNewswire Inc.Applied Therapeutics Announces Positive Topline Results of Pivotal Phase 2 ACTION-Galactosemia Study of AT-007 in Galactosemi...NASDAQ:APLTApplied Therapeutics Inc
23/12/201917:57Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:APLTApplied Therapeutics Inc
23/12/201912:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APLTApplied Therapeutics Inc
19/12/201923:38Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:APLTApplied Therapeutics Inc
19/12/201900:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APLTApplied Therapeutics Inc
16/12/201913:00GlobeNewswire Inc.Applied Therapeutics to Ring Nasdaq Closing Bell on December 17thNASDAQ:APLTApplied Therapeutics Inc
13/12/201922:58Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:APLTApplied Therapeutics Inc
06/12/201913:00GlobeNewswire Inc.Applied Therapeutics Announces Presentation of Pre-Clinical Data Highlighting AT-001 for Treatment of Diabetic Cardiomyopathy...NASDAQ:APLTApplied Therapeutics Inc
05/12/201913:00GlobeNewswire Inc.Applied Therapeutics Announces Presentations Outlining the Design and Rationale for the ARISE-HF Pivotal Study of AT-001 for ...NASDAQ:APLTApplied Therapeutics Inc
21/11/201919:18Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:APLTApplied Therapeutics Inc
15/11/201913:00GlobeNewswire Inc.Applied Therapeutics Announces Presentation of Clinical Data Highlighting AT-001 for the Treatment of Diabetic Cardiomyopathy...NASDAQ:APLTApplied Therapeutics Inc
13/11/201922:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APLTApplied Therapeutics Inc
13/11/201913:00GlobeNewswire Inc.Applied Therapeutics Reports Third Quarter 2019 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
12/11/201913:00GlobeNewswire Inc.Applied Therapeutics, Inc. Announces Pricing of $20 Million Private Placement of Common StockNASDAQ:APLTApplied Therapeutics Inc
16/10/201913:00GlobeNewswire Inc.Applied Therapeutics to Present Data Highlighting AT-007 for the Treatment of Galactosemia at the American Society of Human G...NASDAQ:APLTApplied Therapeutics Inc
17/09/201913:00GlobeNewswire Inc.Applied Therapeutics to Present Preclinical Data Highlighting AT-001 for the Treatment of Diabetic Cardiomyopathy at the 55th...NASDAQ:APLTApplied Therapeutics Inc
13/09/201913:00GlobeNewswire Inc.Applied Therapeutics to Present Data Highlighting AT-001 for the Treatment of Diabetic Cardiomyopathy at the Heart Failure So...NASDAQ:APLTApplied Therapeutics Inc
04/09/201913:00GlobeNewswire Inc.Applied Therapeutics Announces Initiation of Phase 3 Registrational Trial of AT-001 in Diabetic Cardiomyopathy (ARISE-HF)NASDAQ:APLTApplied Therapeutics Inc
28/08/201913:00GlobeNewswire Inc.Applied Therapeutics to Present at Baird’s 2019 Global Healthcare ConferenceNASDAQ:APLTApplied Therapeutics Inc
12/08/201913:00GlobeNewswire Inc.Applied Therapeutics Reports Second Quarter 2019 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
08/08/201913:00GlobeNewswire Inc.Applied Therapeutics Reports AT-007 SAD Data from Healthy Volunteer Portion of Phase 1/2 ACTION-Galactosemia StudyNASDAQ:APLTApplied Therapeutics Inc
24/06/201913:00GlobeNewswire Inc.Applied Therapeutics Announces Initiation of Phase 1/2 Study of AT-007 in GalactosemiaNASDAQ:APLTApplied Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APLT

La tua Cronologia

BIT
P1ZG21
NLBNPIT1ZG21 20241220 35
LSE
NXG
Nex Group
COIN
FETUSD
Fetch
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network